Incannex Healthcare IXHL
NASDAQ IXHL
$3.36 -0.01 (-0.45%)
As of: Sep 9, 2026 · 12:59 PM EDT

Incannex Healthcare (IXHL) Income from Continuing Operations (2022 - 2026)

Incannex Healthcare's (IXHL) quarterly Income from Continuing Operations came in at -$3.9 million in Q1 2026, up 2.14% year-over-year from -$3.8 million in Q1 2025, and up 40.45% quarter-over-quarter from -$6.5 million in Q4 2025.

Analysis

Incannex Healthcare (IXHL) Income from Continuing Operations (2022 - 2026) Analysis & Trends

Incannex Healthcare has disclosed Income from Continuing Operations across 5 years of filings, most recently posting -$3.9 million for Q1 2026.

  • In Q1 2026, Income from Continuing Operations rose 2.14% year-over-year to -$3.9 million; the TTM figure through Mar 2026 stood at -$48.4 million (down 122.97% YoY), while the FY2025 annual figure was -$46.9 million, down 154.0% from the prior year.
  • Income from Continuing Operations came in at -$3.9 million for Q1 2026 at Incannex Healthcare, up from -$6.5 million in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of -$726000.0 in Q3 2023 to a low of -$31.6 million in Q2 2025.
  • Average Income from Continuing Operations over 5 years is -$6.6 million, with a median of -$5.3 million recorded in 2023.
  • Year-over-year, Income from Continuing Operations sank 646.56% in 2024 and soared 34.21% in 2025.
  • Over 5 years, Income from Continuing Operations stood at -$2.9 million in 2022, then plunged by 79.61% to -$5.2 million in 2023, then fell by 12.46% to -$5.9 million in 2024, then decreased by 10.64% to -$6.5 million in 2025, then soared by 40.45% to -$3.9 million in 2026.
  • Per Business Quant data, the three most recent Income from Continuing Operations figures were -$3.9 million in Q1 2026, -$6.5 million in Q4 2025, and -$6.4 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Johnson & Johnson 643.50 Bn 622.74 Bn 17.26 Bn 5.53 Bn
2 AbbVie 440.29 Bn 433.72 Bn 12.70 Bn 3.62 Bn
3 Merck 364.93 Bn 357.79 Bn 12.21 Bn -1.34 Bn
4 Novartis Ag 266.65 Bn 258.96 Bn 11.24 Bn 5.28 Bn
5 Pfizer 158.92 Bn 147.22 Bn 10.94 Bn -246.00 Mn
6 Sanofi 52.46 Bn 45.08 Bn 10.79 Bn 2.16 Bn
7 Revolution Medicines 44.32 Bn 44.32 Bn - -644.37 Mn
8 Incyte 25.32 Bn 20.78 Bn 1.57 Bn 585.61 Mn
9 United Therapeutics 21.42 Bn 18.75 Bn 683.80 Mn 333.00 Mn
10 Incannex Healthcare 41.43 Mn 41.43 Mn - -3.88 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -3.88 Mn
Dec 31, 2025 -6.52 Mn
Sep 30, 2025 -6.41 Mn
Jun 30, 2025 -31.60 Mn
Mar 31, 2025 -3.97 Mn
Dec 31, 2024 -5.89 Mn
Sep 30, 2024 -5.42 Mn
Jun 30, 2024 -6.43 Mn
Mar 31, 2024 -6.03 Mn
Dec 31, 2023 -5.24 Mn
Sep 30, 2023 -726,000.00
Jun 30, 2023 -4.17 Mn
Mar 31, 2023 -3.57 Mn
Dec 31, 2022 -2.92 Mn